These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inotropic and chronotropic effects of two stereoisomers of butidrine, a new adrenergic beta-blocking agent, on isolated rabbit heart and rat auricles. Bertaccini G; Impicciatore M; Visioli O; Malagnino G Farmaco Sci; 1968 Mar; 23(3):183-96. PubMed ID: 5713108 [No Abstract] [Full Text] [Related]
44. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action. Clark BJ; Saameli K; Troxler F Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983 [No Abstract] [Full Text] [Related]
45. Structure-activity relationship of the beta adrenoreceptor blocking agents. Laddu AR; Somani P Eur J Pharmacol; 1969 Nov; 8(2):167-70. PubMed ID: 4391503 [No Abstract] [Full Text] [Related]
46. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade. Nayler WG; Carson V Cardiovasc Res; 1973 Jan; 7(1):22-9. PubMed ID: 4144407 [No Abstract] [Full Text] [Related]
47. Pharmacology of M & B 17803A in man and dog. Briant RH; Dollery CT; Fenyvesi T; George CF Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577 [No Abstract] [Full Text] [Related]
48. Pharmacological properties of a new beta-receptor blocking agent. Clark B; Saameli K Triangle; 1970; 9(8):300-8. PubMed ID: 4397310 [No Abstract] [Full Text] [Related]
49. Coronary vasomotor responses to cardiac sympathetic nerve stimulation in the dog treated with beta adrenoceptor blocking agents. Takenaka F; Ishihara T Jpn J Pharmacol; 1972 Oct; 22(5):721-3. PubMed ID: 4405463 [No Abstract] [Full Text] [Related]
50. [Beta-adrenolytic effect as well as influence of INPEA and MJ 1999 on refractory period and contractility of the guinea pig atrium]. Wagner J; Schümann HJ Experientia; 1970; 26(2):163-4. PubMed ID: 4391796 [No Abstract] [Full Text] [Related]
51. The effect of oxprenolol on cardiac intracellular potentials in relation to its anti-arrhythmic, local anaesthetic and other properties. Vaughan Williams EM; Papp JG Postgrad Med J; 1970 Nov; ():Suppl:22-32. PubMed ID: 5494361 [No Abstract] [Full Text] [Related]
52. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon. Alexandre JM; Menard J; Chevillard C; Schmitt H Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344 [No Abstract] [Full Text] [Related]
53. [Influence of a new beta receptor blockader on hemodynamics]. Bross W; Kustrzycki A; Olejak B; Bross T; Koltowski R; Masiak M Med Klin; 1972 Mar; 67(11):373-81. PubMed ID: 4401684 [No Abstract] [Full Text] [Related]
55. [The effects of a beta-adrenergic blocking agent (INPEA) on systemic and coronary hemodynamics in the dog]. Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E Boll Soc Ital Biol Sper; 1967 Mar; 43(6):313-5. PubMed ID: 6056650 [No Abstract] [Full Text] [Related]
56. Effect of various drugs on electrical and mechanical parameters of atrial muscle. Spilker B; Shevde S Eur J Pharmacol; 1971 Jul; 15(2):145-50. PubMed ID: 4403547 [No Abstract] [Full Text] [Related]
57. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor]. Grün G; Byon KY; Kaufmann R; Fleckenstein A Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592 [No Abstract] [Full Text] [Related]
58. Studies on cardiovascular drugs. 5. 1-Amino-3-phenoxy-2-propanol derivatives as -adrenergic blocking agents. Nakanishi M; Muro T; Chihara Y; Imamura H; Nakao T J Med Chem; 1972 Jan; 15(1):45-8. PubMed ID: 4399806 [No Abstract] [Full Text] [Related]